Current Neuropharmacology Template
Get your Current Neuropharmacology paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.3
How to Use the Current Neuropharmacology Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 7 August, 2026
Submitting to Current Neuropharmacology goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Current Neuropharmacology guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the Current Neuropharmacology Template?
It is a manuscript shell aligned to Current Neuropharmacology. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Current Neuropharmacology journal page before you draft.
What's actually in a Current Neuropharmacology submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Current Neuropharmacology guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Current Neuropharmacology guide for authors before you submit.
What does this Current Neuropharmacology Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for Current Neuropharmacology.
- Edit the prompt with your topic and article type, and note any requirement from the Current Neuropharmacology guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through the journal's submission system.
Current Neuropharmacology Template Structure at a Glance
| Element | Current Neuropharmacology requirement |
|---|---|
| Abstract | Structured abstract required with explicit sub-headings for original research articles, systematic reviews, and meta-analyses. Maximum 250 words. Required sub-headings: Introduction/Objective (summarize objective/purpose), Methods (research design, methodology, conduct of study), Results (main conclusions/findings with statistical data), Discussion (interpret findings in relation to existing literature, highlight significance, address limitations, suggest future research), and Conclusion (overview of key findings and implications). Headings may vary but must state purpose, participant details, measurements, methods, main findings, and conclusion. Review articles and other article types also require structured abstracts not exceeding 250 words |
| Main text | Review Articles: 6000-10000 words (excluding figures, structures, photographs, schemes, tables); Mini-Reviews: 3000-6000 words; Research Articles: 4000-6000 words; Systematic Reviews: 4000-6000 words; Short Communications: 2000-3000 words; Randomized Drug Clinical Trial Studies: 4000-6000 words; Editorials: 1000-1500 words (no abstract required); Commentaries: less than 3000 words (including abstract, main text, references, figure legends); Perspectives: 1500-1800 words; Industry News and Patent News: about 1000 words (no abstract required) |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 6 to 8 keywords required. Keywords should be important and relevant terms that researchers will search for. They should be contained in the title and appear several times in the article. For biomedical fields, MeSH terms are recommended as a good 'common vocabulary' source |
| References | ACS (American Chemical Society) or Vancouver style preferred. All references must be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. Superscript should be avoided in in-text citations and reference section. All authors must be cited (no use of 'et al.' for 6 or fewer authors in ACS; for Vancouver, list all if 6 or fewer, use 3 authors then et al. if more than 6). References must be complete and accurate before submission |
| Peer review | Double-blind (double-anonymous) peer review. The identities of both the reviewer and author are kept undisclosed to each other, ensuring anonymity and maintaining confidentiality throughout the entire review procedure. Usually reviewed by two to three neutral eminent experts |
| Submission | bentham.manuscriptpoint.com/journals/cn/ |
Quick Tips for Using the Current Neuropharmacology Template
Read the Current Neuropharmacology guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Current Neuropharmacology in under a page.
Best Practices
Skim two or three recent Current Neuropharmacology papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Current Neuropharmacology journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the Current Neuropharmacology guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.
